rs375040526
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_005045.4(RELN):c.4843G>C(p.Asp1615His) variant causes a missense change. The variant allele was found at a frequency of 0.0000452 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005045.4 missense
Scores
Clinical Significance
Conservation
Publications
- lissencephaly with cerebellar hypoplasiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Norman-Roberts syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
- familial temporal lobe epilepsy 7Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal dominant epilepsy with auditory featuresInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ankylosing spondylitisInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- complex neurodevelopmental disorderInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000723  AC: 11AN: 152192Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000160  AC: 4AN: 250516 AF XY:  0.0000222   show subpopulations 
GnomAD4 exome  AF:  0.0000424  AC: 62AN: 1461762Hom.:  0  Cov.: 32 AF XY:  0.0000399  AC XY: 29AN XY: 727184 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000723  AC: 11AN: 152192Hom.:  0  Cov.: 32 AF XY:  0.0000538  AC XY: 4AN XY: 74342 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases    Uncertain:1 
The c.4843G>C (p.D1615H) alteration is located in exon 33 (coding exon 33) of the RELN gene. This alteration results from a G to C substitution at nucleotide position 4843, causing the aspartic acid (D) at amino acid position 1615 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7    Uncertain:1 
This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 1615 of the RELN protein (p.Asp1615His). This variant is present in population databases (rs375040526, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with RELN-related conditions. ClinVar contains an entry for this variant (Variation ID: 576903). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RELN protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at